These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3144959)

  • 21. [Antiplatelet drugs].
    Małyszko J; Myśliwiec M
    Przegl Lek; 1992; 49(8):271-3. PubMed ID: 1302347
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of sera, basic fibroblast growth factor, heparin and cyclic AMP-stimulation on proliferation of human vascular endothelial cells.
    Gillis C; Jonzon B; Haegerstrand A
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1131-8. PubMed ID: 8747094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring the new antithrombotic drugs.
    Walenga JM; Hoppensteadt DA
    Semin Thromb Hemost; 2004 Dec; 30(6):683-95. PubMed ID: 15630675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of smooth muscle cell proliferation and neointimal growth by low-anticoagulant heparin.
    Völker W; Böhm A; Schmidt A; Svahn CM; Gellerbring AK; Mattsson C; Ekvärn S; Robenek H; Buddecke E
    Arzneimittelforschung; 1995 May; 45(5):546-50. PubMed ID: 7612053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
    Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
    Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naftazone accelerates human saphenous vein endothelial cell proliferation in vitro.
    Klein-Soyer C; Bloy C; Archipoff G; Beretz A; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1995; 37(3):187-92. PubMed ID: 7567435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.
    Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV
    Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral heparins.
    Hiebert LM
    Clin Lab; 2002; 48(3-4):111-6. PubMed ID: 11934211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin suppresses lymphatic endothelial cell proliferation induced by vascular endothelial growth factor C in vitro.
    Cao G; Wu JX; Wu QH
    Chin Med J (Engl); 2009 Jul; 122(13):1570-4. PubMed ID: 19719950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A laboratory method for parallel determination of platelet aggregation and thrombin generation.
    Köstenberger M; Gallistl S; Cvirn G; Muntean W
    Clin Lab; 2004; 50(1-2):41-8. PubMed ID: 15000219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anticoagulants and platelet aggregation inhibitors in urology].
    Verdy E
    Prog Urol; 1997 Apr; 7(2):326-32. PubMed ID: 9264780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bimodal concentration-dependent effect of thrombin on endothelial cell proliferation and growth factor release in culture.
    Borrelli V; Sterpetti AV; Coluccia P; Randone B; Cavallaro A; Santoro D'Angelo L; Cucina A
    J Surg Res; 2001 Oct; 100(2):154-60. PubMed ID: 11592785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mast cell-derived heparin proteoglycans as a model for a local antithrombotic.
    Lassila R; Jouppila A
    Semin Thromb Hemost; 2014 Nov; 40(8):837-44. PubMed ID: 25393636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial cell interactions with heparin.
    Tobelem G
    Semin Thromb Hemost; 1989 Apr; 15(2):197-9. PubMed ID: 2546256
    [No Abstract]   [Full Text] [Related]  

  • 36. Rapid molecular size characterization of heparins by high pressure liquid chromatography.
    Sugisaka N; Petracek FJ
    Fed Proc; 1977 Jan; 36(1):89-92. PubMed ID: 556606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological equivalence of beef lung and hog musosal heparins.
    Silverglade A
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):91-103. PubMed ID: 808395
    [No Abstract]   [Full Text] [Related]  

  • 38. [The non-anticoagulant action of heparins: prospects].
    Tobelem G
    Rev Prat; 1988 May; 38(15):957-60. PubMed ID: 2455930
    [No Abstract]   [Full Text] [Related]  

  • 39. Heparins: varying effects on cell proliferation in vitro and lack of correlation with anticoagulant activity.
    Lippman MM; Mathews MB
    Fed Proc; 1977 Jan; 36(1):55-9. PubMed ID: 830557
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
    Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.